Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinib

Assessing the relationship of patient global assessment of disease activity and health related quality of life by SF-36 with other patient-reported outcomes in rheumatoid arthritis: post hoc analyses of data from phase 3 trials of baricitinib

Bibliographic Details
Main Authors: Strand, V, Sebba, A, Scardo, S, Quebe, A, Zaremba-Pechmann, L, Taylor, P, Sholter, D
Format: Conference item
Language:English
Published: Journal of Rheumatology 2022
Description
Summary:

Similar Items